For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Doctors’ dark thoughts during COVID

Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
Bismark M, Scurrah K, Pascoe A et al. Thoughts of suicide or self-harm among Australian healthcare workers during the COVID-19 pandemic. Aust N Z J Psychiatry 2022;48674221075540 (online 7 February).
https://pubmed.ncbi.nlm.nih.gov/35128948/
Eggleton K, Bui N, Goodyear-Smith F. COVID-19 impact on New Zealand general practice: rural–urban differences. Rural and Remote Health 2022; 22:7185.
https://doi.org/10.22605/RRH7185
Every-Palmer S, Jenkins M, Gendall P, et al. Psychological distress, anxiety, family violence, suicidality, and wellbeing in New Zealand during the COVID-19 lockdown: A cross-sectional study. PLoS ONE 2022;15(11):e0241658